Sakaki H

No ORCID on file · 2 papers in corpus
2024
Scientific reports ·doi:10.1038/s41598-024-72938-3

Ovarian cancer (OC) is the most lethal gynecologic cancer, mainly due to late diagnosis with widespread peritoneal spread at first presentation. We performed metabolomic analyses of ovarian and paired control tissues using capillary electro…

other 2016
Oncotarget ·doi:10.18632/oncotarget.8395

A phase 2 clinical trial investigating the efficacy and safety of AS602801, a newly developed JNK inhibitor, in the treatment of inflammatory endometriosis is complete. We are now examining whether AS602801 acts against human cancer cells i…